Skip to main content
    E

    Embecta Corp (EMBC)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $6.25
    -0.21 (-3.25%)

    Market Cap: $366.02M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Embecta Corp (EMBC) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Embecta are AngioDynamics (ANGO), Pro-Dex (PDEX) and Anbio Biotechnology Class A Ordinary Shares (NNNN). Embecta trades at 3.1x earnings, against a median of 24.8x for the 6 of these companies with a P/E. By market cap, Embecta ranks 7th of the 13 companies on this page; Becton Dickinson and Company (BDX) is the largest at $59.39B.

    Peer Comparison

    EMBC's ROIC of 18.4% is above the peer median of 6.7%, and its revenue growth of -8.1% is below the median of 9.5%. It yields 0.64%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Embecta (EMBC)$366.02M3.1x0.3x8.6%18.4%-8.1%0.64%
    AngioDynamics Inc (ANGO)$499.19MN/A1.5x-10.1%N/A6.9%0.00%
    Pro-Dex Inc (PDEX)$210.11M18.0x2.7x15.1%19.0%11.0%0.00%
    Anbio Biotechnology Class A Ordinary Shares (NNNN)$167.66MN/A19.7x74.1%N/A73.9%0.00%
    Sanara Medtech Inc (SMTI)$297.06MN/A2.6x-2.7%16.9%8.0%0.00%
    Utah Medical Products Inc (UTMD)$204.92M21.7x6.6x30.5%6.7%-12.1%1.71%
    OraSure Technologies Inc (OSUR)$249.95MN/A2.1x-41.7%N/A14.1%0.00%
    Becton Dickinson and Company (BDX)$59.39B16.4x2.6x5.9%5.0%-10.5%1.94%
    KORU Medical Systems, Inc. (KRMD)$160.49M163.3x3.7x-1.8%N/A11.2%0.00%
    JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)$557.18MN/A0.8x6.0%-0.5%-9.7%0.00%
    Azenta Inc (AZTA)$1.91B96.4x3.5x-26.9%N/A5.1%0.00%
    LeMaitre Vascular Inc (LMAT)$1.79B28.0x6.5x23.5%9.5%11.3%1.30%
    Kestra Medical Technologies, Ltd. Common Stock (KMTS)$1.71BN/A15.3x-140.4%-48.8%59.9%0.00%
    Peer median$398.13M24.8x3.1x2.1%6.7%9.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Embecta, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Instruments & Supplies.

    CompanyAboutPeers
    AngioDynamics Inc (ANGO)
    AngioDynamics, Inc. designs, manufactures and sells various medical, surgical and diagnostic devices for the treatment of peripheral vascular disease...
    ANGO competitors
    Pro-Dex Inc (PDEX)
    Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide.
    PDEX competitors
    Anbio Biotechnology Class A Ordinary Shares (NNNN)
    Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa...
    Sanara Medtech Inc (SMTI)
    Sanara MedTech Inc. develops, markets and distributes skin and wound care products to physicians, hospitals, clinics...
    SMTI competitors
    Utah Medical Products Inc (UTMD)
    Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.
    UTMD competitors
    OraSure Technologies Inc (OSUR)
    OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe...
    OSUR competitors
    Becton Dickinson and Company (BDX)
    Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices...
    BDX competitors
    KORU Medical Systems, Inc. (KRMD)
    Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures...
    KRMD competitors
    JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)
    Jin Medical International Ltd. designs and manufactures wheelchairs and living aids products.
    Azenta Inc (AZTA)
    Azenta Inc. is a premier provider of sample management solutions and life science tools...
    AZTA competitors
    LeMaitre Vascular Inc (LMAT)
    LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide.
    LMAT competitors
    Kestra Medical Technologies, Ltd. Common Stock (KMTS)
    Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
    KMTS competitors

    Frequently Asked Questions About EMBC

    Who are Embecta's main competitors?

    The companies most similar to Embecta include AngioDynamics (ANGO), Pro-Dex (PDEX), Anbio Biotechnology Class A Ordinary Shares (NNNN), Sanara Medtech (SMTI) and Utah Medical Products (UTMD), listed from the closest match.

    Who is Embecta's biggest competitor?

    Becton Dickinson and Company (BDX) is the largest of the similar companies at $59.39B; AngioDynamics (ANGO) is the closest match by business profile, size, sector and industry.

    How does EMBC stock compare with its competitors?

    EMBC's P/E is 3.1x against a peer median of 24.8x; its P/S is 0.3x against a peer median of 3.1x; its net margin is 8.6% against a peer median of 2.1%.

    Which of Embecta's competitors pays a higher dividend?

    Embecta has a forward dividend yield of 0.64%. Becton Dickinson and Company (BDX), Utah Medical Products (UTMD) and LeMaitre Vascular (LMAT) have higher forward dividend yields; Becton Dickinson and Company (BDX) has the highest at 1.94%.

    Is Embecta bigger than its competitors?

    No. Embecta is 7th by market cap among the 13 companies on this page; the largest is Becton Dickinson and Company (BDX) at $59.39B.